Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Changing Prevalence of Lower Airway Infections in Young Children with Cystic Fibrosis.

Breuer O, Schultz A, Turkovic L, de Klerk N, Keil AD, Brennan S, Harrison J, Robertson C, Robinson PJ, Sly PD, Ranganathan S, Stick SM, Caudri D.

Am J Respir Crit Care Med. 2019 Sep 1;200(5):590-599. doi: 10.1164/rccm.201810-1919OC.

PMID:
30811949
2.

Evaluation of Soluble CD48 Levels in Patients with Allergic and Nonallergic Asthma in Relation to Markers of Type 2 and Non-Type 2 Immunity: An Observational Study.

Breuer O, Gangwar RS, Seaf M, Barhoum A, Kerem E, Levi-Schaffer F.

J Immunol Res. 2018 Sep 16;2018:4236263. doi: 10.1155/2018/4236263. eCollection 2018.

3.

Predicting disease progression in cystic fibrosis.

Breuer O, Caudri D, Stick S, Turkovic L.

Expert Rev Respir Med. 2018 Nov;12(11):905-917. doi: 10.1080/17476348.2018.1519400. Epub 2018 Sep 13. Review.

PMID:
30173593
4.

Homozygous loss-of-function mutations in MNS1 cause laterality defects and likely male infertility.

Ta-Shma A, Hjeij R, Perles Z, Dougherty GW, Abu Zahira I, Letteboer SJF, Antony D, Darwish A, Mans DA, Spittler S, Edelbusch C, Cindrić S, Nöthe-Menchen T, Olbrich H, Stuhlmann F, Aprea I, Pennekamp P, Loges NT, Breuer O, Shaag A, Rein AJJT, Gulec EY, Gezdirici A, Abitbul R, Elias N, Amirav I, Schmidts M, Roepman R, Elpeleg O, Omran H.

PLoS Genet. 2018 Aug 27;14(8):e1007602. doi: 10.1371/journal.pgen.1007602. eCollection 2018 Aug.

5.

Understanding the Role of Minor Molybdenum Doping in LiNi0.5Co0.2Mn0.3O2 Electrodes: from Structural and Surface Analyses and Theoretical Modeling to Practical Electrochemical Cells.

Breuer O, Chakraborty A, Liu J, Kravchuk T, Burstein L, Grinblat J, Kauffman Y, Gladkih A, Nayak P, Tsubery M, Frenkel AI, Talianker M, Major DT, Markovsky B, Aurbach D.

ACS Appl Mater Interfaces. 2018 Sep 5;10(35):29608-29621. doi: 10.1021/acsami.8b09795. Epub 2018 Aug 23.

PMID:
30095889
6.

The clinical significance of oropharyngeal cultures in young children with cystic fibrosis.

Breuer O, Caudri D, Akesson L, Ranganathan S, Stick SM, Schultz A; AREST CF.

Eur Respir J. 2018 May 17;51(5). pii: 1800238. doi: 10.1183/13993003.00238-2018. Print 2018 May.

PMID:
29678944
7.

MARS variant associated with both recessive interstitial lung and liver disease and dominant Charcot-Marie-Tooth disease.

Rips J, Meyer-Schuman R, Breuer O, Tsabari R, Shaag A, Revel-Vilk S, Reif S, Elpeleg O, Antonellis A, Harel T.

Eur J Med Genet. 2018 Oct;61(10):616-620. doi: 10.1016/j.ejmg.2018.04.005. Epub 2018 Apr 12.

8.

Side effects of medications used to treat childhood interstitial lung disease.

Breuer O, Schultz A.

Paediatr Respir Rev. 2018 Sep;28:68-79. doi: 10.1016/j.prrv.2018.03.002. Epub 2018 Mar 17. Review.

PMID:
29627169
9.

A quality improvement intervention to reduce emergency department radiography for bronchiolitis.

Reiter J, Breuer A, Breuer O, Hashavya S, Rekhtman D, Kerem E, Cohen-Cymberknoh M.

Respir Med. 2018 Apr;137:1-5. doi: 10.1016/j.rmed.2018.02.014. Epub 2018 Feb 19.

PMID:
29605191
10.

Attention deficit hyperactivity disorder symptoms in patients with cystic fibrosis.

Cohen-Cymberknoh M, Tanny T, Breuer O, Blau H, Mussaffi H, Kadosh D, Gartner S, Salinas A, Bentur L, Nir V, Gur M, Reiter J, Shoseyov D, Kerem E, Berger I.

J Cyst Fibros. 2018 Mar;17(2):281-285. doi: 10.1016/j.jcf.2017.11.020. Epub 2017 Dec 19.

PMID:
29269187
11.

Clinical impact of Pseudomonas aeruginosa colonization in patients with Primary Ciliary Dyskinesia.

Cohen-Cymberknoh M, Weigert N, Gileles-Hillel A, Breuer O, Simanovsky N, Boon M, De Boeck K, Barbato A, Snijders D, Collura M, Pradal U, Blau H, Mussaffi H, Price M, Bentur L, Gur M, Aviram M, Picard E, Shteinberg M, Livnat G, Rivlin J, Hiller N, Shoseyov D, Amirav I, Kerem E.

Respir Med. 2017 Oct;131:241-246. doi: 10.1016/j.rmed.2017.08.028. Epub 2017 Sep 1.

PMID:
28947038
12.

Predictors of Prolonged Hospitalizations in Pediatric Complicated Pneumonia.

Breuer O, Picard E, Benabu N, Erlichman I, Reiter J, Tsabari R, Shoseyov D, Kerem E, Cohen-Cymberknoh M.

Chest. 2018 Jan;153(1):172-180. doi: 10.1016/j.chest.2017.09.021. Epub 2017 Sep 21.

PMID:
28943281
13.

Autosomal dominant gain of function STAT1 mutation and severe bronchiectasis.

Breuer O, Daum H, Cohen-Cymberknoh M, Unger S, Shoseyov D, Stepensky P, Keller B, Warnatz K, Kerem E.

Respir Med. 2017 May;126:39-45. doi: 10.1016/j.rmed.2017.03.018. Epub 2017 Mar 22.

14.

Food Safety Crisis Management-A Comparison between Germany and the Netherlands.

van Asselt ED, van der Fels-Klerx HJ, Breuer O, Helsloot I.

J Food Sci. 2017 Feb;82(2):477-483. doi: 10.1111/1750-3841.13585. Epub 2017 Feb 1.

PMID:
28146273
15.

Complicated community acquired pneumonia in childhood: Different types, clinical course, and outcome.

Erlichman I, Breuer O, Shoseyov D, Cohen-Cymberknoh M, Koplewitz B, Averbuch D, Erlichman M, Picard E, Kerem E.

Pediatr Pulmonol. 2017 Feb;52(2):247-254. doi: 10.1002/ppul.23523. Epub 2016 Jul 8.

PMID:
27392317
16.

Variable phenotypic presentation of a novel FOXF1 missense mutation in a single family.

Reiter J, Szafranski P, Breuer O, Perles Z, Dagan T, Stankiewicz P, Kerem E.

Pediatr Pulmonol. 2016 Sep;51(9):921-7. doi: 10.1002/ppul.23425. Epub 2016 May 4.

PMID:
27145217
17.

Eradication failure of newly acquired Pseudomonas aeruginosa isolates in cystic fibrosis.

Cohen-Cymberknoh M, Gilead N, Gartner S, Rovira S, Blau H, Mussaffi H, Rivlin J, Gur M, Shteinberg M, Bentur L, Livnat G, Aviram M, Picard E, Tenenbaum A, Armoni S, Breuer O, Shoseyov D, Kerem E.

J Cyst Fibros. 2016 Nov;15(6):776-782. doi: 10.1016/j.jcf.2016.04.006. Epub 2016 May 1.

18.

Treatment of cystic fibrosis in low-income countries.

Cohen-Cymberknoh M, Shoseyov D, Breuer O, Shamali M, Wilschanski M, Kerem E.

Lancet Respir Med. 2016 Feb;4(2):91-2. doi: 10.1016/S2213-2600(15)00507-X. No abstract available.

PMID:
26868623
19.

Hepatopulmonary Syndrome in Patients With Cystic Fibrosis and Liver Disease.

Breuer O, Shteyer E, Wilschanski M, Perles Z, Cohen-Cymberknoh M, Kerem E, Shoseyov D.

Chest. 2016 Feb;149(2):e35-e38. doi: 10.1016/j.chest.2015.10.040.

20.

Reversible airway obstruction in cystic fibrosis: Common, but not associated with characteristics of asthma.

Levine H, Cohen-Cymberknoh M, Klein N, Hoshen M, Mussaffi H, Stafler P, Breuer O, Kerem E, Blau H.

J Cyst Fibros. 2016 Sep;15(5):652-9. doi: 10.1016/j.jcf.2016.01.003. Epub 2016 Jan 28.

21.

The Impact of Prior Antibiotic Therapy on Outcomes in Children Hospitalized for Community-Acquired Pneumonia.

Lavi E, Breuer O.

Curr Infect Dis Rep. 2016 Jan;18(1):3. doi: 10.1007/s11908-015-0509-2.

PMID:
26715113
22.

CFTR potentiator therapy ameliorates impaired insulin secretion in CF patients with a gating mutation.

Tsabari R, Elyashar HI, Cymberknowh MC, Breuer O, Armoni S, Livnat G, Kerem E, Zangen DH.

J Cyst Fibros. 2016 May;15(3):e25-7. doi: 10.1016/j.jcf.2015.10.012. Epub 2015 Nov 4.

23.

Implementation of a Policy Change: Replacement of Nebulizers by Spacers for the Treatment of Asthma in Children.

Breuer O, Shoseyov D, Kerem E, Brooks R.

Isr Med Assoc J. 2015 Jul;17(7):421-4.

24.

Antibiotic treatment for children hospitalized with community-acquired pneumonia after oral therapy.

Breuer O, Blich O, Cohen-Cymberknoh M, Averbuch D, Kharasch S, Shoseyov D, Kerem E.

Pediatr Pulmonol. 2015 May;50(5):495-502. doi: 10.1002/ppul.23159. Epub 2015 Feb 4.

PMID:
25652187
25.

Thyroid hormone reduces PCSK9 and stimulates bile acid synthesis in humans.

Bonde Y, Breuer O, Lütjohann D, Sjöberg S, Angelin B, Rudling M.

J Lipid Res. 2014 Nov;55(11):2408-15. doi: 10.1194/jlr.M051664. Epub 2014 Aug 29.

26.

Continuous intravenous β-lactam antibiotics in cystic fibrosis patients with severe drug hypersensitivity.

Breuer O, Cohen-Cymberknoh M, Armoni S, Kerem E, Shoseyov D.

Ann Allergy Asthma Immunol. 2014 Aug;113(2):229-30. doi: 10.1016/j.anai.2014.05.014. Epub 2014 Jun 13. No abstract available.

PMID:
24934107
27.

VKORC1-dependent pharmacokinetics of intravenous and oral phylloquinone (vitamin K1) mixed micelles formulation.

Marinova M, Lütjohann D, Breuer O, Kölsch H, Westhofen P, Watzka M, Mengel M, Stoffel-Wagner B, Hartmann G, Coch C, Oldenburg J.

Eur J Clin Pharmacol. 2013 Mar;69(3):467-75. doi: 10.1007/s00228-012-1362-y. Epub 2012 Aug 5.

28.

A novel severe N-terminal splice site KISS1R gene mutation causes hypogonadotropic hypogonadism but enables a normal development of neonatal external genitalia.

Breuer O, Abdulhadi-Atwan M, Zeligson S, Fridman H, Renbaum P, Levy-Lahad E, Zangen DH.

Eur J Endocrinol. 2012 Aug;167(2):209-16. doi: 10.1530/EJE-12-0127. Epub 2012 May 22.

PMID:
22619348
29.

Neurological complications and pandemic influenza A (H1N1) virus infection.

Omari I, Breuer O, Kerem E, Berger I.

Acta Paediatr. 2011 Jul;100(7):e12-6. doi: 10.1111/j.1651-2227.2011.02188.x. Epub 2011 Mar 1.

PMID:
21284719
30.

Pharmacokinetics of ropivacaine in patients with chronic end-stage liver disease.

Jokinen MJ, Neuvonen PJ, Lindgren L, Höckerstedt K, Sjövall J, Breuer O, Askemark Y, Ahonen J, Olkkola KT.

Anesthesiology. 2007 Jan;106(1):43-55.

PMID:
17197844
31.

Functional architecture of the mammalian striatum: mouse vascular and striosome organization and their anatomic relationships.

Breuer O, Lawhorn C, Miller T, Smith DM, Brown LL.

Neurosci Lett. 2005 Sep 16;385(3):198-203.

PMID:
15970379
32.

Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.

Fagerholm U, Breuer O, Swedmark S, Hoogstraate J.

J Pharm Pharmacol. 2005 May;57(5):587-97.

PMID:
15901348
34.

Transformation of subcutaneous nitric oxide into nitrate in the rat.

Benthin G, Björkhem I, Breuer O, Sakinis A, Wennmalm A.

Biochem J. 1997 May 1;323 ( Pt 3):853-8.

35.

Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation.

Lütjohann D, Breuer O, Ahlborg G, Nennesmo I, Sidén A, Diczfalusy U, Björkhem I.

Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9799-804.

39.

Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry.

Dzeletovic S, Breuer O, Lund E, Diczfalusy U.

Anal Biochem. 1995 Feb 10;225(1):73-80.

PMID:
7778789
40.

Cholesterol 7 alpha-hydroxylase is up-regulated by the competitive inhibitor 7-oxocholesterol in rat liver.

Breuer O, Sudjana-Sugiaman E, Eggertsen G, Chiang JY, Björkhem I.

Eur J Biochem. 1993 Aug 1;215(3):705-10.

42.

The antioxidant butylated hydroxytoluene protects against atherosclerosis.

Björkhem I, Henriksson-Freyschuss A, Breuer O, Diczfalusy U, Berglund L, Henriksson P.

Arterioscler Thromb. 1991 Jan-Feb;11(1):15-22.

PMID:
1987993
45.

Enzymatic conversion of leukotriene B4 to 6-trans-leukotriene B4 by rat kidney homogenates.

Breuer O, Hammarström S.

Biochem Biophys Res Commun. 1987 Feb 13;142(3):667-73.

PMID:
3030296

Supplemental Content

Loading ...
Support Center